Hydroxychloroquine (HCQS) 200 mg: Drug or Cure for COVID-19?

 

 

From the Merck Manuals Professional Edition, Hydroxychloroquine (HCQS) 200 mg also known as Plaquenil has been used for decades to treat rheumatoid arthritis and other autoimmune diseases such as lupus and sarcoidosis. It was released on the market in 1956 with Bayer Pharmaceuticals being the original producer of it. This medication or drug, HCQS, is also an anti-malarial drug used to cure acute malaria infections.

 

What is HCQS?

Hydroxychloroquine, also known as HCQS, is a medication that is used to treat the symptoms of chronic inflammatory diseases like systemic lupus erythematosus and rheumatoid arthritis. In addition, this drug has been shown to be effective in treating the symptoms of certain forms of malaria and toxoplasmosis. However, there are some side effects associated with HCQS that can range from mild to life-threatening. These include dizziness and an increased risk of seizures. It is important to weigh the potential benefits against the possible risks before taking this medication.

 

How does it work?

COVID-19 is a virus that affects the brain and causes symptoms such as paralysis, seizures, headaches, and difficulty walking. In an effort to find a cure to this virus, doctors have been looking for treatments. One of these treatments is Hydroxychloroquine (HCQS). HCQS is a drug that has been around since the 1960s and was approved by the FDA in 1994 to treat rheumatoid arthritis. It works by reducing inflammation and slowing down the body's immune system response to reduce joint pain and stiffness.

 

What are the side effects?

Side effects of HCQS are not common, but some people may experience GI upset and diarrhea. Other side effects that have been reported include dizziness, headache, fever, anorexia, nausea and vomiting. In rare cases erythema multiforme as well as hypersensitivity reactions including rash with fever and eosinophilia have been reported. Serious adverse events are very uncommon with this medication.

 

Who should take it?

COVID-19 is a neurological disorder that causes chronic, debilitating headaches. HCQS is an anti-malarial drug that has been shown to reduce the frequency of headaches by up to 60%. But does it work for everyone? Let's break down the specifics.

 

Is it a cure for COVID-19?

Hydroxychloroquine is a drug commonly prescribed to treat various forms of arthritis and psoriasis. However, it may also be an effective treatment for chronic fatigue syndrome, also known as COVID-19. In fact, HCQS has been used in clinical trials to study its effectiveness in treating the condition. There are many symptoms of CFS that are similar to those seen with rheumatoid arthritis and other conditions, such as fatigue and joint pain; all of which can be alleviated by HCQS. The most common side effects include nausea, headache and dizziness but these typically subside within 2 weeks of starting treatment.


Everything You Need to Know About Ivermectin: From Dosage to Side Effects

    Ivermectin (also known as Stromectol) is an antiparasitic medication used to treat infections caused by parasites such as lice, round...